Professur für Translationale Frauenheilkunde und Geburtshilfe


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study (2025) Rangelova E, Stoop TF, van Ramshorst TM, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, et al. Journal article Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial (2025) Cardoso F, O’Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, et al. Journal article Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer (2025) Conforti F, Nekljudova V, Sala I, Ascari R, Solbach C, Untch M, Denkert C, et al. Journal article Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers. (2025) Häberle L, Erber R, Gaß P, Hein A, Niklos M, Volz B, Hack C, et al. Journal article Style-Extracting Diffusion Models for Semi-supervised Histopathology Segmentation (2025) Öttl M, Wilm F, Steenpaß J, Qiu J, Rübner M, Hartmann A, Beckmann M, et al. Conference contribution, Original article Correction to: Genetic drivers and cellular selection of female mosaic X chromosome loss (Nature, (2024), 631, 8019, (134-141), 10.1038/s41586-024-07533-7) (2024) Liu A, Genovese G, Zhao Y, Pirinen M, Zekavat SM, Kentistou KA, Yang Z, et al. Journal article, Erratum Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer (2024) Nelson BH, Hamilton P, Phung MT, Milne K, Harris B, Thornton S, Stevens D, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article Digitalization is not everything but everything is nothing without digitalization Digitalisierung ist nicht alles, aber alles ist nichts ohne Digitalisierung (2024) Kiechle M, Wallwiener S, Wagner U, Fasching P Journal article